These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 1425925)

  • 21. Beta 2-microglobulin independent presentation of exogenously added foreign peptide and endogenous self-epitope by MHC class I alpha-chain to a cross-reactive CD8+ CTL clone.
    Zügel U; Schoel B; Kaufmann SH
    J Immunol; 1994 Nov; 153(9):4070-80. PubMed ID: 7523514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
    Bodey B; Bodey B; Kaiser HE
    In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytotoxic T lymphocyte precursor cells specific for the major histocompatibility complex class I-like antigen, Qa-2, require CD4+ T cells to become primed in vivo and to differentiate into effector cells in vitro.
    Muraoka S
    Eur J Immunol; 1991 Sep; 21(9):2095-103. PubMed ID: 1679712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different types of allospecific CTL clones identified by their ability to recognize peptide loading-defective target cells.
    Aosai F; Ohlen C; Ljunggren HG; Höglund P; Franksson L; Ploegh H; Townsend A; Kärre K; Stauss HJ
    Eur J Immunol; 1991 Nov; 21(11):2767-74. PubMed ID: 1936122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of antitumor immunity using bone marrow-generated dendritic cells.
    Porgador A; Snyder D; Gilboa E
    J Immunol; 1996 Apr; 156(8):2918-26. PubMed ID: 8609412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of overlapping epitopes in mutant ras oncogene peptides that activate CD4+ and CD8+ T cell responses.
    Abrams SI; Stanziale SF; Lunin SD; Zaremba S; Schlom J
    Eur J Immunol; 1996 Feb; 26(2):435-43. PubMed ID: 8617315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of dendritic cells in the regulation of class I restricted cytotoxic T lymphocyte responses.
    Boog CJ; Boes J; Melief CJ
    J Immunol; 1988 May; 140(10):3331-7. PubMed ID: 2452183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On the mechanisms of immunodominance in cytotoxic T lymphocyte responses to minor histocompatibility antigens.
    Pion S; Fontaine P; Desaulniers M; Jutras J; Filep JG; Perreault C
    Eur J Immunol; 1997 Feb; 27(2):421-30. PubMed ID: 9045913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunization against tumor and minor histocompatibility antigens by eluted cellular peptides loaded on antigen processing defective cells.
    Franksson L; Petersson M; Kiessling R; Kärre K
    Eur J Immunol; 1993 Oct; 23(10):2606-13. PubMed ID: 8405061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigen-presenting cells pulsed with unfractionated tumor-derived peptides are potent tumor vaccines.
    Nair SK; Boczkowski D; Snyder D; Gilboa E
    Eur J Immunol; 1997 Mar; 27(3):589-97. PubMed ID: 9079797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunization of mice with the N-terminal (1-272) fragment of simian virus 40 large T antigen (without adjuvants) specifically primes cytotoxic T lymphocytes.
    Schirmbeck R; Zerrahn J; Kuhröber A; Deppert W; Reimann J
    Eur J Immunol; 1993 Jul; 23(7):1528-34. PubMed ID: 8325328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD4+ T cell-mediated killing of major histocompatibility complex class II-positive antigen-presenting cells (APC). III. CD4+ cytotoxic T cells induce apoptosis of APC.
    Grogg D; Hahn S; Erb P
    Eur J Immunol; 1992 Jan; 22(1):267-72. PubMed ID: 1346113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phagocyte-induced antigen-specific activation of unprimed CD8+ T cells in vitro.
    De Bruijn ML; Jackson MR; Peterson PA
    Eur J Immunol; 1995 May; 25(5):1274-85. PubMed ID: 7539754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo priming of cytotoxic T lymphocyte responses in relation to in vitro up-regulation of major histocompatibility complex class I molecules by short synthetic peptides.
    Zhou X; Abdel Motal UM; Berg L; Jondal M
    Eur J Immunol; 1992 Dec; 22(12):3085-90. PubMed ID: 1446701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antigen recognition by H-2-restricted cytolytic T lymphocytes: inhibition of cytolysis by anti-CD8 monoclonal antibodies depends upon both concentration and primary sequence of peptide antigen.
    Maryanski JL; Pala P; Cerottini JC; MacDonald HR
    Eur J Immunol; 1988 Nov; 18(11):1863-6. PubMed ID: 3144458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human tonsillar dendritic cell-induced T cell responses: analysis of molecular mechanisms using monoclonal antibodies.
    King PD; Katz DR
    Eur J Immunol; 1989 Apr; 19(4):581-7. PubMed ID: 2786468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of murine leukemia viruses on the function of dendritic cells.
    Gabrilovich DI; Roberts MS; Harvey JJ; Botcherby M; Bedford PA; Knight SC
    Eur J Immunol; 1993 Nov; 23(11):2932-8. PubMed ID: 8223870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Major histocompatibility complex class I-binding peptides are recycled to the cell surface after internalization.
    Abdel Motal UM; Zhou X; Joki A; Siddiqi AR; Srinivasa BR; Stenvall K; Dahmén J; Jondal M
    Eur J Immunol; 1993 Dec; 23(12):3224-9. PubMed ID: 8258337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TCR-independent killing of B cell malignancies by anti-third-party CTLs: the critical role of MHC-CD8 engagement.
    Lask A; Goichberg P; Cohen A; Goren-Arbel R; Milstein O; Aviner S; Feine I; Ophir E; Reich-Zeliger S; Hagin D; Klein T; Nagler A; Berrebi A; Reisner Y
    J Immunol; 2011 Aug; 187(4):2006-14. PubMed ID: 21753148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DC-expressed MHC class I single-chain trimer-based vaccines prime cytotoxic T lymphocytes against exogenous but not endogenous antigens.
    Ordaz ML; Larmonier N; Lybarger L
    Cell Immunol; 2010; 262(2):141-9. PubMed ID: 20199770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.